News Ranitidine: doctors should switch patients to alternative, says health department BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6087 (Published 17 October 2019) Cite this as: BMJ 2019;367:l6087 Article Related content Metrics Responses Peer review Related articles News FDA recalls ranitidine medicines over potential cancer causing impurity Published: 02 October 2019; BMJ 367 doi:10.1136/bmj.l5832 News GSK recalls ranitidine products over potential carcinogen contamination Published: 08 October 2019; BMJ 367 doi:10.1136/bmj.l5933 News Ranitidine: all products are out of stock as investigations continue Published: 28 November 2019; BMJ 367 doi:10.1136/bmj.l6746 See more BEACON trial in colorectal cancer is “single worst reported,” says critic BMJ October 16, 2019, 367 l6057; DOI: https://doi.org/10.1136/bmj.l6057 GSK recalls ranitidine products over potential carcinogen contamination BMJ October 08, 2019, 367 l5933; DOI: https://doi.org/10.1136/bmj.l5933 Bowel cancer: experts advise against routine testing for everyone over 50 BMJ October 03, 2019, 367 l5829; DOI: https://doi.org/10.1136/bmj.l5829 FDA recalls ranitidine medicines over potential cancer causing impurity BMJ October 02, 2019, 367 l5832; DOI: https://doi.org/10.1136/bmj.l5832 Clostridioides difficile: diagnosis and treatments BMJ August 20, 2019, 366 l4609; DOI: https://doi.org/10.1136/bmj.l4609 Cited by... Ranitidine: all products are out of stock as investigations continueFulltext PDF
